The role of NPM1 as biomarker of the targeted therapy efficacy in chronic lymphocytic leukemia patients
2021/43/O/NZ5/01885
Keywords
Descriptors
- NZ5_007: Leczenie chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Medyczny w Lublinie, Wydział Lekarski
Voivodeship: lubelskie
Principal investigator (from the host institution)
prof. Krzysztof Georgios Giannopoulos
Number of co-investigators in the project: 2
Call
PRELUDIUM BIS 3 – announced on 2021-09-15
- Amount awarded
- 497 960 PLN
- Project start date
- 2022-10-01
- Project end date
- 2025-09-30
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
Targeting splicing for hematological malignancies therapy.
- Authors:
- Monika Szelest, Krzysztof Giannopoulos
- Academic press:
- BMC Genomics (year: 2024, volume: 25(1), pages: 1067), Publisher: Springer Nature
- Status:
- Published
- DOI:
- 10.1186/s12864-024-10975-y – link to the publication
-
Biological relevance of alternative splicing in hematologic malignancies
- Authors:
- Monika Szelest, Krzysztof Giannopoulos
- Academic press:
- Molecular medicine (year: 2024, volume: 30(1), pages: 62), Publisher: Springer Nature
- Status:
- Published
- DOI:
- 10.1186/s10020-024-00839-2 – link to the publication